Past Event

Alzheimer's Disease: An Overview

23 May 2017
London, United Kingdom
 

What is Alzheimer’s Disease: An Overview?

  • Alzheimer’s Disease: An Overview is a rapid and progressive one-day course
  • Leading specialists offer their expert knowledge and experience face-to-face
  • An education programme designed specifically for pharmaceutical, medical technology & biotechnology industry personnel
  • The day involves lectures, discussion and question and answer sessions with our expert faculty
  • This course provides an excellent grounding for people new to this area of medicine. Those who have already been working in this field will enhance their knowledge and benefit from the clinical perspective provided by the programme

What will I learn from this Alzheimer’s Disease training?

  • This training provides an overview of Alzheimer’s Disease from both a clinical management and a drug development perspective
  • Delegates are offered a general understanding of Alzheimer’s Disease and its neurobiology
  • Discussion on clinical presentation and disease staging
  • Review of pharmacological and other treatment options
  • Clinical trial design issues and a review of ongoing research in Alzheimer’s Disease

Topics included in this Alzheimer’s Disease training:

  • Dementia
  • Neurobiology of Alzheimer’s Disease
  • Clinical presentation and differential diagnosis
  • Stages of Alzheimer’s Disease
  • Pharmacological treatment
  • Clinical trial design issues
  • Holistic patient care
  • Ongoing research

Faculty:

Paul Francis, PhD, Professor of Neurochemistry, Director, Brains for Dementia Research, Wolfson Centre for Age-Related Disease, King’s College London, London, UK

Prof Craig W Ritchie, Professor of the Psychiatry of Ageing, Centre for Clinical Brain Sciences, University of Edinburgh & Visiting Professor, Imperial College London, UK

Is this Alzheimer’s Disease course for me?

This Alzheimer’s Disease training course has been developed for pharmaceutical, medical technology, biotechnology and associated healthcare industry personnel working in product management, strategic marketing, research and development, sales, training, medical affairs and pharmacovigilance of drugs used in Alzheimer’s Disease and dementia

Related Events

Comments